Atlas Trials

Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

Clinical trial NCT00741780 · COMPLETED

Trial details

NCT number
NCT00741780
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple MyelomaAutologous Transplantation
Start date
2006-06-01
Primary completion
2011-07-01
Enrollment
164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.